trimebutine has been researched along with Helicobacter Infections in 2 studies
Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trimebutine maleate is a prokinetic drug that hastens gastric emptying, by inducing the release of gastrointestinal agents such as motilin and gastrin." | 6.72 | The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis. ( Boziki, M; Deretzi, G; Doulberis, M; Fludaras, I; Gavalas, E; Grigoriadis, N; Karafoulidou, E; Katsinelos, P; Kesidou, E; Koukoufiki, A; Kountouras, J; Liatsos, C; Papaefthymiou, A; Polyzos, SA; Simeonidou, C; Sofou, E; Taloumtzis, C; Theotokis, P; Touloumtzi, M; Vardaka, E, 2021) |
| "Trimebutine maleate is a prokinetic drug that hastens gastric emptying, by inducing the release of gastrointestinal agents such as motilin and gastrin." | 2.72 | The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis. ( Boziki, M; Deretzi, G; Doulberis, M; Fludaras, I; Gavalas, E; Grigoriadis, N; Karafoulidou, E; Katsinelos, P; Kesidou, E; Koukoufiki, A; Kountouras, J; Liatsos, C; Papaefthymiou, A; Polyzos, SA; Simeonidou, C; Sofou, E; Taloumtzis, C; Theotokis, P; Touloumtzi, M; Vardaka, E, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boziki, M | 1 |
| Grigoriadis, N | 1 |
| Papaefthymiou, A | 1 |
| Doulberis, M | 1 |
| Polyzos, SA | 1 |
| Gavalas, E | 1 |
| Deretzi, G | 1 |
| Karafoulidou, E | 1 |
| Kesidou, E | 1 |
| Taloumtzis, C | 1 |
| Theotokis, P | 1 |
| Sofou, E | 1 |
| Katsinelos, P | 1 |
| Vardaka, E | 1 |
| Fludaras, I | 1 |
| Touloumtzi, M | 1 |
| Koukoufiki, A | 1 |
| Simeonidou, C | 1 |
| Liatsos, C | 1 |
| Kountouras, J | 2 |
| Zavos, C | 1 |
| Chatzopoulos, D | 1 |
1 review available for trimebutine and Helicobacter Infections
| Article | Year |
|---|---|
The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis.
Topics: Brain Diseases; Dysbiosis; Gastrointestinal Agents; Gastrointestinal Diseases; Gastrointestinal Micr | 2021 |
1 other study available for trimebutine and Helicobacter Infections
| Article | Year |
|---|---|
H pylori infection and reflux oesophagitis.
Topics: Cohort Studies; Drug Therapy, Combination; Esophagitis; Gastroesophageal Reflux; Gastrointestinal Ag | 2004 |